PRS
IMGN

Pinkerton Retirement Specialists’s Immunogen Inc IMGN Stock Holding History

Pinkerton Retirement Specialists’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-55
Closed – – 523
2016
Q4 		$0 Hold
55
– – ﹤0.01% 659
2016
Q3 		$0 Hold
55
– – ﹤0.01% 671
2016
Q2 		$0 Buy
+55
New +$345 ﹤0.01% 662

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinkerton Retirement Specialists's IMGN Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Immunogen Inc (IMGN) in Q1 2017, closing a stake of 55 shares.

Pinkerton Retirement Specialists first reported a position in IMGN in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 135 funds tracked by Wall St. Rank hold IMGN as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Immunogen Inc position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 55 Immunogen Inc shares in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in Immunogen Inc in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Immunogen Inc position peaked at $0 in Q4 2016.
  • 135 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.